- Home
- FGEN vs GSIW Comparison
FGEN vs GSIW Comparison
Compare FGEN & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- GSIW
- Stock Information
- Founded
- FGEN 1993
- GSIW 2016
- Country
- FGEN United States
- GSIW Hong Kong
- Employees
- FGEN N/A
- GSIW N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- GSIW
- Sector
- FGEN Health Care
- GSIW
- Exchange
- FGEN Nasdaq
- GSIW Nasdaq
- Market Cap
- FGEN 33.5M
- GSIW 27.2M
- IPO Year
- FGEN 2014
- GSIW 2023
- Fundamental
- Price
- FGEN $8.07
- GSIW $1.75
- Analyst Decision
- FGEN Strong Buy
- GSIW
- Analyst Count
- FGEN 1
- GSIW 0
- Target Price
- FGEN $250.00
- GSIW N/A
- AVG Volume (30 Days)
- FGEN 60.0K
- GSIW 2.6M
- Earning Date
- FGEN 08-05-2025
- GSIW 01-01-0001
- Dividend Yield
- FGEN N/A
- GSIW N/A
- EPS Growth
- FGEN N/A
- GSIW N/A
- EPS
- FGEN N/A
- GSIW N/A
- Revenue
- FGEN $6,996,000.00
- GSIW $1,313,795.00
- Revenue This Year
- FGEN N/A
- GSIW N/A
- Revenue Next Year
- FGEN N/A
- GSIW N/A
- P/E Ratio
- FGEN N/A
- GSIW N/A
- Revenue Growth
- FGEN N/A
- GSIW N/A
- 52 Week Low
- FGEN $4.50
- GSIW $0.35
- 52 Week High
- FGEN $38.25
- GSIW $12.30
- Technical
- Relative Strength Index (RSI)
- FGEN 65.01
- GSIW 72.13
- Support Level
- FGEN $7.03
- GSIW $1.26
- Resistance Level
- FGEN $5.73
- GSIW $1.66
- Average True Range (ATR)
- FGEN 0.58
- GSIW 0.14
- MACD
- FGEN 0.33
- GSIW -0.02
- Stochastic Oscillator
- FGEN 94.43
- GSIW 92.25
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.